Prima Launches New Botanical Elixir Collection: Innovative CBD drink powders optimized for functional benefits
Ryan Allway
September 18th, 2019
News
LOS ANGELES, Sept. 18, 2019 /PRNewswire/ — Prima, the science-based beauty and wellness brand focused on hemp-based cannabinoids, announced today the launch of the Botanical Elixir Collection, individual-use powdered beverage infusions made with broad spectrum hemp CBD, active adaptogens and herbs for functional support of mood, focus and rest.
Known for their unwavering commitment to purity, potency and efficacy, Prima has created fast-dissolving, water-soluble powders through a plant-based, patent-pending technology which processes their high quality hemp CBD extract into a unique format that is optimized for bioavailability.
“The most important element that we consider — besides the purity of your CBD — is whether or not it is in a format that your body can easily absorb. We use an innovative encapsulation process that is designed to allow the cannabinoids to be far more effective than hemp oil alone, maximizing the benefit of the ingredients,” said Prima Chief Operating Officer Laurel Angelica Myers.
Meticulously selected adaptogens and herbs work synergistically with Prima’s hemp CBD to drive efficacy and maximize benefits, through an easy-to-use, mix-in powder in any hot or cold beverage.
THE GO-TO: 10 mg broad spectrum hemp CBD — for everyday mood, balance and essential wellbeing. ($48)
BRAIN FUEL: 10 mg broad spectrum hemp CBD with Ashwagandha, Gingko, Lion’s Mane, and Rhodiola — for energy, focus and vitality. ($55)
REST EASY: 10 mg broad spectrum hemp CBD with Chamomile, Passionflower, Hope, Valerian, and L-Theanine — to calm, relax and prepare the body and mind for sleep. ($55)
Prima’s Botanical Elixirs, each designed with a different need state in mind, are now available in boxes of 20 stick pre-measurable packs or as a sampler box of 6 stick packs (2 per formula for $18) called the Trifecta.
As with all Prima products, the elixirs are formulated with high quality whole hemp extract sustainably grown in Oregon. Each elixir is doctor formulated, vegan, gluten free, non-GMO, non-intoxicating and sweetener free.
“Prima is dedicated to bringing consumers the purest, most potent and technologically advanced products on the market. Our Botanical Elixirs are a manifestation of these uncompromising standards and values, in an incredibly effective, easy-to-use format,” said Prima CEO Christopher Gavigan.
Prima’s Botanical Elixirs were formulated to support and optimize your wellness routine — from supercharging your coffee in the morning to supporting a more restful sleep at night. In addition, they can be incorporated into a variety of beverages for all occasions, even for the sober-curious audience.
“Our consumers are at the heart of everything we do — and we’re here to help. We’re so pleased to be able to offer a delightful drink experience with results you can feel instantly… one that promotes wellbeing and that helps better manage our busy, modern lives — morning, noon and night,” said Prima Chief Education Officer Jessica Assaf.
The Botanical Elixir Collection is Prima’s second launch within the supplement category. The brand’s vegan softgel, The Daily, has been its best selling product since launching on June 5, 2019.
ABOUT PRIMA
Prima is a best-in-class consumer wellness and purpose-driven brand focused on hemp-based cannabinoids. Its core purpose is to bridge the gap between science, nature and the human body through education, social impact and functionally innovative botanical products. Prima is built on the essential principle that balance is a critical part of overall health, happiness and betterment. Prima is a privately held Public Benefit Corporation (PBC) based in Santa Monica, CA. You can shop Prima directly at prima.co and at select retailers such as Erewhon, Calmist and Standard Dose New York.
@prima
#liveprima
prima.co
For further information, please contact:
Kate Alper
Communité
kate@communite.co
SOURCE Prima
Related Linkshttp://prima.co
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
ManifestSeven (M7), formerly known as MJIC, is the first integrated omnichannel platform for legal cannabis, merging compliant distribution with a retail superhighway.
Gage Cannabis Co. is innovating and curating the highest quality cannabis experiences possible for cannabis consumers in the state of Michigan and bringing internationally renowned brands to market.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
